Biosimilars: Promises Made. Promises Kept?

J Cutan Med Surg. 2021 May-Jun;25(3):241-242. doi: 10.1177/12034754211007814.
No abstract available

Keywords: Tumor Necrosis Factor-alpha / antagonists & inhibitors; biologics; biosimilars; drug approval; drug cost; humira; rituximab; therapeutic monoclonal antibodies.

Publication types

  • Editorial

MeSH terms

  • Biosimilar Pharmaceuticals*
  • Canada
  • Drug Approval
  • Humans
  • Skin Diseases / drug therapy*

Substances

  • Biosimilar Pharmaceuticals